Patents
More topics under "C07J - Steroids" (42,482)
C07J 1 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 17 beta by a carbon atom, e.g. oestrane, androstane (4,828)
C07J 11 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, not substituted in position 3 (283)
C07J 13 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having a carbon-to-carbon double bond from or to position 17 (764)
C07J 15 - Stereochemically pure steroids containing carbon, hydrogen, halogen, or oxygen, having a partially or totally inverted skeleton, e.g. retrosteroids, l-isomers (136)
C07J 17 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,111)
C07J 19 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 by a lactone ring (362)
C07J 21 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, having an oxygen-containing hetero ring spiro-condensed with the cyclopenta[a]hydrophenanthrene skeleton (1,576)
C07J 3 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by one carbon atom (1,033)
C07J 31 - Normal steroids containing one or more sulfur atoms not belonging to a hetero ring (2,027)
C07J 33 - Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (413)
C07J 41 - Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring (4,637)
C07J 43 - Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta[a]hydrophenanthrene skeleton (2,516)
C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937)
C07J 51 - Normal steroids with unmodified cyclopenta[a]hydrophenanthrene skeleton not provided for in groups (1,565)
C07J 53 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by condensation with carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms (1,809)
C07J 61 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one or two atoms (90)
C07J 63 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms (2,707)
C07J 65 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of two rings, each by one atom (2)
C07J 67 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by expansion of two rings, each by one atom (2)
C07J 69 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by contraction of only one ring by one atom and expansion of only one ring by one atom (107)
C07J 7 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms (2,018)
C07J 71 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton is condensed with a heterocyclic ring (3,845)
C07J 73 - Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms (1,160)
C07J 75 - Processes for the preparation of steroids, in general (1,657)
C07J 9 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane (4,897)
Patents for C07J - Steroids (408)
05/1997
05/28/1997EP0775154A1 Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
04/1997
04/16/1997CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives
04/01/1997US5616742 Dechlorination, alkenylation
03/1997
03/19/1997EP0763541A1 11-(Substituted phenyl)-estra-4,9-diene derivatives
03/19/1997EP0763054A1 Process for preparing delta 9,11 and 21-chloro corticosteroids
12/1996
12/10/1996US5583228 Reductase inhibitor; skin disorders
08/1996
08/07/1996EP0725074A2 Compounds suitable for use as intermediates in the preparation of Androst-3,5-dien-3-carboxy derivatives
07/1996
07/16/1996US5536714 Steroid derivatives for the treatment of prostatic hypertrophy their preparation and uses
04/1996
04/10/1996EP0705273A1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof
04/10/1996EP0705272A1 Novel process for preparing 17 beta-substituted 4-azaandrostane derivatives
03/1996
03/26/1996US5502222 Process for preparing delta 9,11 and 21-chloro corticosteroids
03/26/1996US5502045 Use of a stanol fatty acid ester for reducing serum cholesterol level
12/1995
12/26/1995US5478956 8-En-19 11 β-bridged steroids, their production and pharmaceutical preparations containing them
12/07/1995WO1995032989A1 Process for preparing δ9,11 and 21-chloro corticosteroids
11/1995
11/22/1995CN1030319C 20- and 21-amino steroid
10/1995
10/25/1995EP0678097A1 Novel colon- or ileum-specific steroid derivatives
10/04/1995EP0674651A1 Substituted 6-azaandrostenones
09/1995
09/20/1995EP0468012B1 17$g(b)-SUBSTITUTED-4-AZA-5$g(a)-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
05/1995
05/10/1995EP0651643A1 17-ALKYLKETONE STEROIDS USEFUL AS 5-$g(a)-REDUCTASE INHIBITORS
05/03/1995EP0650496A1 Anti-inflammatory compounds for ophthalmic use
01/1995
01/05/1995WO1995000532A1 17-halogeno-4-azaandrostene derivatives and process for the preparation thereof
01/05/1995WO1995000531A1 NOVEL PROCESS FOR PREPARING 17β-SUBSTITUTED 4-AZAANDROSTANE DERIVATIVES
01/04/1995CN1027270C 14,17 beta-ehano-14 beta-estratrienes and estratetranenes, process for their production and pharmaceutical preparations containing them
11/1994
11/24/1994WO1994026769A1 Anti-inflammatory compounds for ophthalmic use
11/23/1994CN1095383A Substituted 6-azaandrostenones
11/23/1994CN1095382A Compounds
10/1994
10/26/1994CN1026324C 11beta-(4-isopropenylbenzene)-4,9-estrobiene, preparation of same and pharmaceutical containing same
09/1994
09/29/1994WO1994014833A3 Substituted 6-azaandrostenones
07/1994
07/21/1994WO1994015947A1 Novel colon- or ileum-specific steroid derivatives
07/21/1994CA2152374A1 Novel colon- or ileum-specific steroid derivatives
07/07/1994WO1994014833A2 Substituted 6-azaandrostenones
07/07/1994CA2152053A1 Substituted 6-azaandrostenones
05/1994
05/04/1994EP0594612A1 A substance for lowering high cholesterol level in serum and a method for preparing the same.
04/1994
04/13/1994EP0591165A1 Heterocyclic steroid compounds
03/1994
03/02/1994CN1083070A Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
01/1994
01/06/1994WO1994000125A1 17-ALKYLKETONE STEROIDS USEFUL AS 5-α-REDUCTASE INHIBITORS
01/06/1994CA2138956A1 17-alkylketone steroids useful as 5-.alpha.-reductase inhibitors
10/1993
10/27/1993EP0567271A2 Steroid derivatives for the treatment of prostatic hypertrophy, their preparation and uses
10/20/1993EP0565553A1 6,7-MODIFIED 11$g(b)-ARYL-4-ESTRENES
06/1993
06/15/1993US5219879 Heterocyclic steroid compounds
05/1993
05/18/1993US5212166 Antiandrogens or 5-alpha reductase inhibitors
12/1992
12/23/1992WO1992022322A1 Lhrh analogs
12/16/1992CN1067057A Process for preparing unsaturated 17 -substituted 3-carboxysteroids
12/09/1992EP0517047A1 Unsaturated 17beta-substituted 3-carboxy steroids
12/01/1992USRE34136 9 alpha, 11 beta-substituted and 11 beta-substituted estranes
11/1992
11/25/1992WO1992020700A1 UNSATURATED 17β-SUBSTITUTED 3-CARBOXY STEROIDS
11/25/1992CA2087953A1 Unsaturated 17.beta. -substituted 3-carboxy steroids
11/12/1992WO1992019640A1 A substance for lowering high cholesterol level in serum and a method for preparing the same
10/1992
10/13/1992US5155107 17β-substituted-4-aza-5α-androstan-3-one derivatives and process for their preparation
10/13/1992CA1308707C 20- and 21-amino steroids
10/07/1992CN1065070A 6,7-modified 11beta-aryl-4-estrene
06/1992
06/25/1992DE4042007A1 6,7-modifizierte-11(beta)-aryl-4-estrene 6,7-modified-11 (beta) -Aryl-4-Estrenes
06/23/1992WO1992011277A1 6,7-MODIFIED 11β-ARYL-4-ESTRENES
06/23/1992CA2099018A1 6,7-modified 11.beta.-aryl-4-estrenes
06/09/1992CA1302923C Process for producing 4-androstene -3,17-dione and 1,4-androstardiene -3,17-dione
06/04/1992DE4038128A1 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate 8-ene-19, 11 (beta) -ueberbrueckte steroids, their production and pharmaceutical compositions containing them
05/1992
05/28/1992WO1992009618A1 8-ENE-19, 11β-BRIDGED STEROIDS, THEIR PREPARATION AND PHARMACEUTICAL FORMULATIONS CONTAINING THEM
05/28/1992CA2097079A1 8-ene-19, 11.bet.beta.-bridged steroids, their preparation and pharma ceutical formulations containing them
02/1992
02/18/1992US5089488 β-(4-isopropenylphenyl)estra-4,9-dienes, their production, and pharmaceutical preparations containing same
01/1992
01/29/1992EP0318490B1 14,17-g(b)-ethano-14-g(b)-estratrienes, process for their manufacture and pharmaceutical preparations containing these
10/1991
10/09/1991EP0450461A2 LHRH Analogs
10/07/1991CA2039908A1 Lhrh analogues
10/02/1991EP0227813B1 11-beta-nitrate-substituted estranes
10/01/1991CA1289944C 11 .beta.-(4-ISOPREPENYLPHENYL)ESTRA-4,9-DIENES, THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING SAME
09/1991
09/25/1991CN1054771A Process for preparation of 17beta-substituted-4-aza-5alpha-androstan-3-one derivatives
09/02/1991WO1991013903A1 Heterocyclic steroid compounds
09/02/1991CA2077680A1 Heterocyclic steroid compounds
08/1991
08/10/1991WO1991012261A1 17β-SUBSTITUTED-4-AZA-5α-ANDROSTAN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION
08/10/1991CA2049318A1 17.beta.-substituted-4-aza-5.alpha.-androstan-3-one derivatives and process for their preparation
05/1991
05/21/1991US5017568 Enzyme inhibitors, carboxylation
05/1990
05/15/1990CA1269102A1 14,17.beta.-ETHANO-14.beta.-ESTRATRIENES AND ESTRATETRAENES, PROCESSES FOR THEIR PRODUCTION, AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
08/1989
08/22/1989US4859370 9 alpha, 11 beta-substituted and 11 beta-substituted estranes
06/1989
06/07/1989EP0318490A1 14,17-g(b)-ETHANO-14-g(b)-ESTRATRIENES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THESE.
05/1989
05/09/1989CA1253806A1 Physically modified beclomethasone dipropionate suitable for use in aerosols
03/1989
03/21/1989US4814327 Antiprogesterone, antiglucocorticord
03/07/1989US4810488 Physically modified beclomethasone dipropionate suitable for use in aerosols
03/07/1989CA1250830A1 Liposomes containing steroid esters
02/1989
02/22/1989EP0205530B1 Physically modified beclomethasone dipropionate suitable for use in aerosols
12/1988
12/06/1988US4789671 14,17β-ethano-14β-estratrienes and estratetraenes, process for their production, and pharmaceutical preparations containing them
05/1988
05/11/1988CN87105307A 11b-(4-isopropenylphenyl)-estra-4,9-dienes, their production, and pharmaceutical preparations containing same
03/1988
03/09/1988CN87105736A 14, 17 beta-ethano-14 beta-estratrienes and estratetraenes, processes for t heir production, and pharmaceutical preparations containing them
01/1988
01/27/1988EP0254670A1 11-beta-(4-isopropenylphenyl)-estra-4,9-diene, their preparation and pharmaceutical compositions containing them
11/1987
11/10/1987US4705783 9α, 11β-substituted and 11β-substituted estranes
09/1987
09/15/1987US4693999 Antiinflammatory, antiallergen agents
07/1987
07/01/1987EP0227588A1 Process for the preparation of androst-4-ene-3,17-dione and androsta-1,4-diene-3,17 dione
06/1987
06/18/1987WO1987003620A1 Process for producing 4-androstene-3,17-dion and 1,4-androstadiene-3,17-dion
03/1987
03/18/1987CN86106226A 20- and 21- amino steroid
01/1987
01/15/1987WO1987000175A1 9alpha, 11beta-SUBSTITUTED AND 11beta-SUBSTITUTED ESTRANES
12/1986
12/30/1986EP0205530A1 Physically modified beclomethasone dipropionate suitable for use in aerosols.
07/1986
07/03/1986WO1986003750A1 Physically modified beclomethasone dipropionate suitable for use in aerosols
06/1986
06/10/1986CA1205744A1 Progestational adjuvant therapy
02/1986
02/05/1986EP0170642A2 Liposomes containing steroid esters
08/1984
08/28/1984CA1173432A1 10-(1,2-propadienyl) steroids as irreversible aromatase inhibitors
11/1983
11/08/1983US4414209 And a halogenated hydrocarbon as a solvate, asthma
01/1983
01/25/1983US4370321 Progestational adjuvant therapy
12/1982
12/21/1982US4364923 Chemical compounds
09/1981
09/15/1981US4289762 Anticarcinogenic
01/1980
01/15/1980CA1069885A1 .delta.15-steroid
07/1979
07/24/1979US4162255 Process for extracting aristolochic acids
06/1979
06/12/1979US4158055 Administration of 16α,17α-cyclopentylidenedioxy-9α-fluor O-11β,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate
1 2 3 4 5